Sulforhodamine B colorimetric assay for cytotoxicity screening
Authors:
Top Cited Papers
- 17 August 2006
- journal article
- research article
- Published by Springer Nature in Nature Protocols
- Vol. 1 (3) , 1112-1116
Abstract
The sulforhodamine B (SRB) assay is used for cell density determination, based on the measurement of cellular protein content. The method described here has been optimized for the toxicity screening of compounds to adherent cells in a 96-well format. After an incubation period, cell monolayers are fixed with 10% (wt/vol) trichloroacetic acid and stained for 30 min, after which the excess dye is removed by washing repeatedly with 1% (vol/vol) acetic acid. The protein-bound dye is dissolved in 10 mM Tris base solution for OD determination at 510 nm using a microplate reader. The results are linear over a 20-fold range of cell numbers and the sensitivity is comparable to those of fluorometric methods. The method not only allows a large number of samples to be tested within a few days, but also requires only simple equipment and inexpensive reagents. The SRB assay is therefore an efficient and highly cost-effective method for screening.Keywords
This publication has 13 references indexed in Scilit:
- An anti-herpes simplex virus-type 1 agent from Xylaria mellisii (BCC 1005)Tetrahedron Letters, 2005
- A Generally Applicable, High-Throughput Screening–Compatible Assay to Identify, Evaluate, and Optimize Antimicrobial Agents for Drug TherapySLAS Discovery, 2004
- Assay of anticancer drugs in tissue cultureAnti-Cancer Drugs, 1996
- Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell linesAnti-Cancer Drugs, 1995
- A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell linesEuropean Journal of Cancer, 1993
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI: Journal of the National Cancer Institute, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell LinesJNCI: Journal of the National Cancer Institute, 1990
- A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitroIn Vitro Cellular & Developmental Biology, 1988
- A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agentsAntiviral Research, 1983